In compliance
with ASX Continuing Disclosure Rules, Genetic Technologies Limited
GENE is pleased to report that it has executed a
of Longmont, Colorado, USA. Under the Agreement,
Eurofins STA is granted non-exclusive rights to a number of GTG
patents relating to its non-coding DNA technology. As with other
similar agreements, the precise commercial terms of the Agreement are
covered by formal confidentiality provisions and cannot be disclosed.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in